Publication of List of Manufacturers Revoked from Licensing for the Manufacture of Therapeutic Goods - Ludwig Institute for Cancer Research LTD and Mesoblast LTD

Administered by Department of Health, Disability and Ageing

Legislation au C2015G00310 In force Gazette

Legislation content

COMMONWEALTH OF AUSTRALIA

Department of Health
Therapeutic Goods Administration

THERAPEUTIC GOODS ACT 1989

 

 

PUBLICATION OF LIST OF MANUFACTURERS REVOKED FROM LICENSING FOR

THE MANUFACTURE OF THERAPEUTIC GOODS

 

I, Dr Harry Rothenfluh, Delegate of the Secretary of the Department of Health, Therapeutic Goods Administration for the purpose of Section 41 of the Therapeutic Goods Act, hereby publish the following details concerning the revocation of a Licence to Manufacture Therapeutic Goods:

 

 

Under Section 41(1)(d) of the Therapeutic Goods Act 1989 the Secretary by notice in writing has revoked the Licence held by:

Ludwig Institute for Cancer Research Ltd – LICENCE NO. MI-01072005-LI-000662-1 OF Austin Hospital Level 6, Harold Stokes Building 145-163 Studley Road, HEIDELBERG, VIC, 3084  – AT THE REQUEST OF THE MANUFACTURER.

Mesoblast Ltd – LICENCE NO. MI-2009-LI-05411-3 OF Peter MacCallum Cancer Centre for Blood Cell Therapies, St Andrews Place, EAST MELBOURNE, VIC, 3002  – AT THE REQUEST OF THE MANUFACTURER.

 

 

(Signed by)

 

Dr Harry Rothenfluh

Manufacturing Quality Branch

Delegate of the Secretary

20 February 2015

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.